Clinical Trials Logo

Recurrence clinical trials

View clinical trials related to Recurrence.

Filter by:

NCT ID: NCT00469131 Completed - Hepatitis C Clinical Trials

Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid

Start date: September 2003
Phase: Phase 3
Study type: Interventional

The aim of this study is to compare immunosuppression protocol of tacrolimus + MMF with that of tacrolimus + steroid for preventing recurrence of hepatitis C after living donor liver transplantation.

NCT ID: NCT00461903 Completed - Atrial Fibrillation Clinical Trials

Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential Hypertension

CTAF-2
Start date: December 2007
Phase: Phase 3
Study type: Interventional

The purpose of this 7- to 13-month study is to determine the efficacy of 8 mg/day oral perindopril to prevent the recurrence of atrial fibrillation (AF) in patients with essential hypertension.

NCT ID: NCT00440310 Completed - Clinical trials for Colorectal Neoplasms

Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases

Start date: February 2007
Phase: Phase 3
Study type: Interventional

The purpose of the study is to assess the overall survival and progression free survival of patients treated with Litx™ + chemotherapy versus chemotherapy alone in the treatment of Colorectal Cancer with recurrent liver metastases, and to demonstrate the safety of Litx™ therapy. Litx™ consists of a light-activated drug, talaporfin sodium (LS11, Light Sciences Oncology, Bellevue, Washington), and a light generating device, composed of light-emitting diodes (LEDs), that is energized by a power controller and percutaneously placed in the target tumor tissue inside the body.

NCT ID: NCT00421876 Completed - Clinical trials for Myocardial Infarction

GlObal Secondary Prevention strategiEs to Limit Event Recurrence After Myocardial Infarction. GOSPEL Study

Start date: December 2000
Phase: N/A
Study type: Interventional

Cardiac rehabilitation programmes are a proven treatment for individuals with recent myocardial infarction, resulting in reduced morbidity and mortality compared to usual care. Unfortunately, following completion of a cardiac rehabilitation programme, risk factors and lifestyle behaviours may deteriorate. The GOSPEL study investigates the benefits of a programme of continued educational and behavioural intervention to achieve optimal long-term secondary prevention goals.

NCT ID: NCT00418457 Completed - Breast Neoplasms Clinical Trials

Regional Anesthesia and Breast Cancer Recurrence

Start date: January 2007
Phase: Phase 3
Study type: Interventional

In this multi-center trial, Stage 1-3 patients having mastectomies or isolated lumpectomy with axillary node dissection will be randomly assigned to thoracic epidural or paravertebral anesthesia/analgesia, or to general anesthesia and morphine analgesia. Participants will be followed for up to 10 years to determine the rate of cancer recurrence or metastasis.

NCT ID: NCT00407654 Completed - Clinical trials for Recurrent Rectal Cancer

VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer

Start date: October 2006
Phase: Phase 2
Study type: Interventional

This phase II trial is studying how well VEGF Trap works in treating patients with previously treated metastatic colorectal cancer. VEGF Trap may stop the growth of colorectal cancer by blocking blood flow to the tumor.

NCT ID: NCT00401323 Completed - Neoplasm Metastasis Clinical Trials

Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Start date: January 1998
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of the study is to compare time to progression and overall survival after treatment with Taxotere plus cisplatin versus cisplatin plus 5-FU (PF treatment group) in the first line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.

NCT ID: NCT00400426 Completed - Clinical trials for Head and Neck Neoplasms

DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer

Start date: November 2006
Phase: Phase 2
Study type: Interventional

Palliative radiotherapy for head and neck cancer is widely used but the effect and side effects are largely unknown. We will study the effect of short hypofractionated palliative radiotherapy (20 Gy in 4 fractions) on symptom intensity and -frequency as weel as side effects

NCT ID: NCT00397540 Completed - Chronic Hepatitis B Clinical Trials

The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)

Start date: October 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of serum hepatitis B virus (HBV) DNA level on intrahepatic recurrence in locally treatable hepatocellular carcinomas (HCCs) related with HBV.

NCT ID: NCT00374426 Completed - Diabetes Clinical Trials

Preventing Depression Recurrence in Diabetes

Start date: March 1998
Phase: Phase 4
Study type: Interventional

To study the effectiveness of sertraline (Zoloft) in treating depression in adults with diabetes. The study will also determine whether depressed diabetic patients who have successfully responded to sertraline (Zoloft) are more likely to have depression recur if the sertraline (Zoloft) is discontinued.